Age as a continuous variable in predicting outcome for neuroblastoma patients with metastatic disease: Impact of tumor biological features

Reviewer: Ryan Smith, MD
OncoLink
Ultima Vez Modificado: 2 de junio del 2003

Translation for this article does not exist